Physician profile
James Henderson Walker
NPI 1871533505
$6,750.92
in general payments reported to CMS, 2019-2025
43 companies · $844 in 2025
The $844 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $1,040 · 2021: $1,484 · 2022: $934 · 2023: $1,064 · 2024: $890 · 2025: $844.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,798.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,798.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,266.17 | 2019-2025 | Xifaxan, Trulance |
| Abbvie INC. | $983.17 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Lilly USA, LLC | $731.87 | 2019-2025 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals LP | $456.94 | 2020-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $329.55 | 2019-2025 | |
| Otsuka America Pharmaceutical, INC. | $318.99 | 2021-2025 | Rexulti |
| Novo Nordisk INC | $299.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $242.44 | 2020-2022 | |
| Allergan, INC. | $212.58 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $193.15 | 2021-2025 | |
| Glaxosmithkline, LLC. | $174.18 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Biohaven Pharmaceuticals, INC. | $163.93 | 2021 | |
| Sanofi-Aventis U.S. LLC | $135.32 | 2019-2020 | |
| Lundbeck LLC | $131.41 | 2023-2025 | Rexulti, Vyepti |
| Abbott Laboratories | $111.17 | 2019-2023 | Freestyle Libre 3 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.